The role of silicone stents in the treatment of cicatricial tracheal stenoses

Citation
F. Puma et al., The role of silicone stents in the treatment of cicatricial tracheal stenoses, J THOR SURG, 120(6), 2000, pp. 1064-1069
Citations number
20
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY
ISSN journal
00225223 → ACNP
Volume
120
Issue
6
Year of publication
2000
Pages
1064 - 1069
Database
ISI
SICI code
0022-5223(200012)120:6<1064:TROSSI>2.0.ZU;2-3
Abstract
Objective: Tracheal stenting for cicatricial stenoses is reserved for patie nts whose lesions are deemed inoperable for local or general reasons. The a im of our study was to verify the long-term results of silicone tracheal st ents in such a clinical setting. Methods: Clinical data of 45 patients treated by tracheal silicone stents, between 1987 and 1999, were reviewed. All patients had highly symptomatic c icatricial stenoses; they were selected for stenting rather than for surger y because of local and general conditions. This series has been divided in two groups according to the purpose of stenting: bridge to surgery or defin itive treatment. Follow-up ranged between 12 and 83 months. Twenty-seven pa tients received a Montgomery T tube (Hood Laboratories, Pembroke, Mass), 16 a Dumon stent (Novatech, Plan de Gras, France), and 2 a Dynamic stent (Rus ch, Kernen, Germany). Results: No procedure-related mortality was observed. Nine patients underwe nt curative resection and reconstruction after a variable stenting period; one had a recurrent stenosis and was treated for palliation with a T tube. Tracheal stenting was performed for palliation as a definitive treatment in 37 patients. Among this group, 11 patients died of unrelated causes at a m edian of 10 months after the endoscopic treatment. The stent was permanentl y removed in 10 after a median interval of 32 months (range 9-70 months); i n 4 others, symptomatic recurrence of the stenosis was observed within 6 we eks of stent removal. None of the patients successfully decannulated had a completely normal tracheal lumen but all remained asymptomatic because the residual stenosis was mild or well tolerated for concomitant limitation of physical activity. Conclusions: Long-term treatment with a silicone stent was safe and well to lerated in cicatricial tracheal stenoses. This procedure can be considered as a bridge to curative surgery or as a definitive treatment. The latter, g enerally performed for palliation, may provide satisfactory therapeutic res ults in selected patients, even in the presence of severe circumferential s tenoses.